C the Signs announced $8 million in funding from Khosla Ventures to support its expansion from the U.K. to the U.S. The investment will enhance its AI-based platform that identifies patients at risk of cancer early, improving detection rates and survival odds.
Company Information
Company
C the Signs
Location
London, England, United Kingdom
About
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease.
In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.
Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
Fundz sees it the moment C the Signs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LondonBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics